Cellular Therapy for Diffuse Large B-Cell Lymphoma

adobestock_292869171.jpg

The goal of this activity is to review currently available CAR T-Cell therapies for diffuse large B-cell lymphoma. Topics to be covered include patient eligibility criteria, complications, outcomes and treatment guidelines.

Instruction format: Enduring Video Presentation
Cost: Complimentary
Credits: 0.5 AMA PRA Category 1 Credit™


Published

December 17, 2020

Expires

December 16, 2021

Related Presenters

Christine Ho, MD

Christine Ho, MD

Assistant Professor of Oncology, Department of Transplant and Cellular Therapy, Roswell Park Comprehensive Cancer Center Buffalo, NY

Supporting Documents